Technical Analysis for SBBP - Strongbridge Biopharma plc

Grade Last Price % Change Price Change
grade F 2.42 -4.72% -0.12
SBBP closed down 4.72 percent on Friday, August 23, 2019, on 46 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical SBBP trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
New 52 Week Closing Low Bearish 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -4.72%
Down 3 Days in a Row Weakness -4.72%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -8.33%
Upper Bollinger Band Touch Strength -8.33%
Crossed Above 20 DMA Bullish -12.00%
Pocket Pivot Bullish Swing Setup -12.00%

Older signals for SBBP ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Strongbridge Biopharma plc, a biopharmaceutical company, through its subsidiary, Cortendo AB (publ), develops, acquires, and commercializes product candidates that target rare diseases. The company's lead product candidate, COR-003 (levoketoconazole), is a cortisol inhibitor that is in the Phase 3 trial for the treatment of endogenous Cushing's syndrome. It also has two product candidates, COR-004 and COR-005 in Phase 2 clinical development to treat acromegaly. In addition, it is developing BP-2001, a pre-clinical product candidate for the treatment of diabetes. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is based in Trevose, Pennsylvania.
Chemistry Biopharmaceutical Organ Systems Chemical Compounds Diabetes Rare Diseases Chloroarenes Treatment Of Diabetes Acromegaly Cushing's Syndrome Adrenal Gland Disorders Cortisol Endogenous Cushing's Syndrome Piperazines
Is SBBP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.52
52 Week Low 2.4
Average Volume 186,587
200-Day Moving Average 4.0856
50-Day Moving Average 2.8484
20-Day Moving Average 2.572
10-Day Moving Average 2.594
Average True Range 0.1565
ADX 14.79
+DI 16.6758
-DI 22.923
Chandelier Exit (Long, 3 ATRs ) 2.4505
Chandelier Exit (Short, 3 ATRs ) 2.8695
Upper Bollinger Band 2.7348
Lower Bollinger Band 2.4092
Percent B (%b) 0.03
BandWidth 12.659409
MACD Line -0.0691
MACD Signal Line -0.0795
MACD Histogram 0.0104
Fundamentals Value
Market Cap 85.51 Million
Num Shares 35.3 Million
EPS -2.93
Price-to-Earnings (P/E) Ratio -0.83
Price-to-Sales 139.82
Price-to-Book 21.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.66
Resistance 3 (R3) 2.69 2.63 2.62
Resistance 2 (R2) 2.63 2.57 2.62 2.61
Resistance 1 (R1) 2.53 2.53 2.50 2.50 2.59
Pivot Point 2.47 2.47 2.46 2.46 2.47
Support 1 (S1) 2.37 2.41 2.34 2.34 2.25
Support 2 (S2) 2.31 2.37 2.30 2.23
Support 3 (S3) 2.21 2.31 2.22
Support 4 (S4) 2.18